Memantine LEK
البلد: الاتحاد الأوروبي
اللغة: الدانماركية
المصدر: EMA (European Medicines Agency)
نشرة المعلومات
(PIL)
16-11-2020
خصائص المنتج
(SPC)
16-11-2020
تقرير التقييم الجمهور
(PAR)
29-04-2013
العنصر النشط:
memantinhydrochlorid
متاح من:
Pharmathen S.A.
ATC رمز:
N06DX01
INN (الاسم الدولي):
memantine
المجموعة العلاجية:
Psychoanaleptics, , Andre demensmedicin
المجال العلاجي:
Alzheimers sygdom
الخصائص العلاجية:
Behandling af patienter med moderat til svær Alzheimers sygdom.
ملخص المنتج:
Revision: 5
الوضع إذن:
autoriseret
تاريخ الترخيص:
2013-04-21
نشرة المعلومات
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
اقرأ الوثيقة كاملة
خصائص المنتج
Skip to main content [European Medicines Agency]
Menu *
EMA WEBSITE TEMPORARILY UNAVAILABLE
This website is currently unavailable due to essential maintenance.
EMERGENCY CONTACT DETAILS
To report a potentially serious problem with a centrally authorised
medicine, call our product emergency hotline on +31 (0)88 781 7600.
To report a product quality defect, including a suspected defect, of a
centrally authorised medicine that could result in a recall or
abnormal restriction on supply, marketing or manufacturing
authorisation holders can call +31 (0)65 008 9457 outside business
hours.
The details of your call may be documented, including personal data if
you provide them (such as your name, contact details and nature of the
issue raised), in accordance with our privacy statement. You can
consult our privacy statement at
https://www.ema.europa.eu/en/about-us/legal/general-privacy-statement
[/en/about-us/legal/general-privacy-statement] once the website is
back online.
RSS feed Twitter YouTube LinkedIn
© 1995-2020 European Medicines Agency
European Union agencies network [European Union agencies network]
An agency of the European Union [European Union flag]
اقرأ الوثيقة كاملة
